Host-microbe interactions and defense mechanisms in the development of amoebic liver abscesses

Clinical Microbiology Reviews

Volumn 22, Issue 1, 2009, Pages 65-75

  Santi Rocca, Julien ^a,b   Rigothier, Marie Christine ^c   Guillén, Nancy ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENTAMOEBA HISTOLYTICA; HISTOPATHOLOGY; HOST PARASITE INTERACTION; HUMAN; INFLAMMATION; INNATE IMMUNITY; LIVER AMEBIASIS; LIVER CIRCULATION; LIVER SINUSOID; NONHUMAN; PARASITE IMMUNITY; PARASITE VIRULENCE; PATHOPHYSIOLOGY; REVIEW; ANIMAL; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY;

ANIMALS; ENTAMOEBA HISTOLYTICA; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER ABSCESS, AMEBIC;

EID: 59649120679     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00029-08     Document Type: Review

References (90)

1. Adams, E. B., and I. N. MacLeod. 1977. Invasive amebiasis. II. Amebic liver abscess and its complications. Medicine (Baltimore) 56:325-334.
2. Ali, I. K., U. Mondal, S. Roy, R. Haque, W. A- Petri, Jr., and C. G. Clark. 2007. Evidence for a link between parasite genotype and outcome of infection with Entamoeba histolytica. J. Clin. Microbiol. 45:285-289.
3. Ali, I. K., S. Solaymani-Mohammadi, J. Akhter, S. Roy, C. Gorrini, A. Calderaro, S. K. Parker, R. Haque, W. A. Petri, and C. G. Clark. 2008. Tissue invasion by Entamoeba histolytica: evidence of genetic selection and/or DNA reorganization events in organ tropism. PLoS Negl. Trop. Dis. 2:e219.
4. Andra, J., R. Herbst, and M. Leippe. 2003. Amoebapores. archaic effector peptides of protozoan origin, are discharged into phagosomes and kill bacteria by permeabilizing their membranes. Dev. Comp. Immunol. 27:291-304.
5. Ankri, S., T. Stolarsky, R. Bracha, F. Padilla-Vaca, and D. Mirelman. 1999. Antisense inhibition of expression of cysteine proteinases affects Entamoeba histolytica -induced formation of liver abscess in hamsters. Infect. Immun. 67:421-422.
6. Arellano, J., J. Granados, E. Perez, C. Felix, and R. R. Kretschmer. 1991. Increased frequency of HLA-DR3 and complotype SC01 in Mexican mestizo patients with amoebic abscess of the liver. Parasite Immunol. 13:23-29.
7. Arellano, J., M. Perez-Rodriguez, M. Lopez-Osuna, J. R. Velazquez, J. Granados, N. Justiniani, J. I. Santos, A. Madrazo, L. Munoz, and R. Kretschmer. 1996. Increased frequency of HLA-DR3 and complotype SCOl in Mexican mestizo children with amoebic abscess of the liver. Parasite Immunol. 18:491-498.
8. Bhattacharya, A., R. Arya, C. G. Clark, and J. P. Ackers. 2000. Absence of lipophosphoglycan-like glycoconjugates in Entamoeba dispa. Parasitology 120:31-35.
9. Blazquez, S., M. C. Rigothier, M. Huerre, and N. Guillen. 2007. Initiation of inflammation and cell death during liver abscess formation by Entamoeba histolytica depends on activity of the galactose/N-acetyl-D- galactosamine lectin. Int. J. Parasitol. 37:425-33.
10. Blazquez, S., C. Zimmer, G. Guigon, J. C. Olivo-Marin, N. Guillen, and E. Labruyere. 2006. Human tumor necrosis factor is a chemoattractant for the parasite Entamoeba histolytica. Infect. lmmun. 74:1407-1411.
11. Bracha, R., Y. Nuchamowitz, M. Leippe, and D. Mirelman. 1999. Antisense inhibition in Entamoeba histolytica causes a decrease in amoebic virulence. Mol. Microbiol. 34:463-472.
12. Braga, L. L., H. Ninomiya, J. J. McCoy, S. Eacker, T. Wiedmer, C. Pham, S. Wood, P. J. Sims, and W. A. Petri, Jr. 1992. Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica. J. Clin. Investig. 90:1131-1137.
13. Bruchhaus, I., T. Jacobs, M. Leippe, and E. Tannich. 1996. Entamoeba histolytica and Entamoeba dispar: differences in numbers and expression of cysteine proteinase genes. Mol. Microbiol. 22:255-263.
14. Bruchhaus, I., S. Richter, and E. Tannich. 1998. Recombinant expression and biochemical characterization of an NADPH:flavin oxidoreductase from Entamoeba histolytica. Biochem. J. 330:1217-1221.
15. Bruchhaus, I., S. Richter, and E. Tannich. 1997. Removal of hydrogen peroxide by the 29 kDa protein of Entamoeba histolytica. Biochem. J. 326: 785-789.
16. Calderon, J., M. de Lourdes Munoz, and H. M. Acosta. 1980. Surface redistribution and release of antibody-induced caps in entamoebae. J. Exp. Med. 151:184-193.
17. Chadee, K, and E. Meerovitch. 1984. The pathogenesis of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus). Am. J. Pathol. 117:71-80.
18. Choi, M. H., D. Sajed, L. Poole, K. Hirata, S. Herdman, B. E. Torian, and S. L. Reed. 2005. An unusual surface peroxiredoxin protects invasive Entamoeba histolytica from oxidant attack. Mol. Biochem. Parasitol. 143:80-89.
19. Cieslak, P. R., H. W. Virgin IV, and S. L. Stanley, Jr. 1992. A severe combined immunodeficient (SCID) mouse model for infection with Entamoeba histolytica. J. Exp. Med. 176:1605-1609.
20. Clark, C. G., U. C. Alsmark, M. Tazreiter, Y. Saito-Nakano, V. Ali, S. Marion, C, Weber, C. Mukherjee, L Bruchhaus, E. Tannich, M, Leippe, T. Sicheritz-Ponten, P. G. Foster, J. Samuelson, C. J. Noel, R. P. Hirt, T. M. Embley, C. A. Gilchrist, B. J. Mann, U. Singh, J. P. Ackers, S. Bhattacharya, A. Bhattacharya, A. Lohia, N, Guillen, M. Duchene, T, Nozaki, and N. Hall. 2007. Structure and content of the Entamoeba histolytica genome. Adv. Parasitol. 65:51-190.
21. Coudrier, E., F. Amblard, C. Zimmer, P. Roux, J. C. Olivo-Marin, M. C. Rigothier, and N. Guillen. 2005. Myosin II and the Gal-GalNAc lectin play a crucial role in tissue invasion by Entamoeba histolytica. Cell. Microbiol. 7:19-27.
22. Coulter, E. D., and D. M. Kurtz, Jr. 2001. A role for rubredoxin in oxidative stress protection in Desulfovibrio vulgaris: catalytic electron transfer to rubrerythrin and two-iron superoxide reductase. Arch. Biochem. Biophys. 394:76-86.
23. Dey, I., K. Keller, A. Belley, and K. Chadee. 2003. Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica. Proc Natl. Acad. Sci. USA 100:13561-13566.
24. Dodson, J, M., P. W. Lenkowski, Jr., A. C. Eubanks, T. F. Jackson, J. Napodano, D. M. Lyerly, L. A. Lockhart, B. J. Mann, and W. A. Petri, Jr. 1999. Infection and immunity mediated by the carbohydrate recognition domain of the Entamoeba histolytica Gal/GalNAe lectin. J. Infect. Dis. 179: 460-466.
25. Dong, Z., H. Wei, R. Sun, and Z. Tian. 2007. The roles of innate immune cells in liver injury and regeneration. Cell. Mol. Immunol. 4:241-252.
26. Elnekave, K., R. Siman-Tov, and S. Ankri. 2003. Consumption of L-arginine mediated by Entamoeba histolytica L-arginase (EhArg) inhibits amoebicidal activity and nitric oxide production by activated macrophages. Parasite Immunol. 25:597-608.
27. Elvevold, K. H., G. L Nedredal, A. Revhaug, and B. Smedsrod. 2004. Scavenger properties of cultivated pig liver endothelial cells. Comp. Hepatol. 3:4.
28. Engelhardt, B., and H. Wolburg. 2004. Transendothelial migration of leukocytes: through the front door or around the side of the house? Eur. J. Immunol. 34:2955-2963.
29. Garcia-Rivera, G., M. A. Rodriguez, R. Ocadiz, M. C. Martinez-Lopez, R. Arroyo, A. Gonzalez-Robles, and E. Orozco. 1999. Entamoeba histolytica: a novel cysteine protease and an adhesin form the 112 kDa surface protein. Mol. Microbiol. 33:556-568.
30. Gauss, K. A., L. K. Nelson-Overton, D. W. Siemsen, Y. Gao, F. R. DeLeo, and M. T. Quinn. 2007. Role of NF-kappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha. J. Leukoc. Biol. 82:729-741.
31. Ghadirian, E., S. D. Somerfield, and P. A. Kongshavn. 1986. Susceptibility of Entamoeba histolytica to oxidants. Infect. Immun. 51:263-267.
32. Gilchrist, C. A., E. Houpt, N. Trapaidze, Z. Fei, O. Crasta, A. Asgharpour, C. Evans, S. Martino-Catt, D. J. Baba, S. Stroup, S. Hamano, G. Ehren-kaufer, M. Okada, IT. Singh, T. Nozaki, B. J. Mann, and W. A. Petri, Jr. 2006. Impact of intestinal colonization and invasion on the Entamoeba histolytica transcriptome. Mol. Biochem. Parasitol. 147:163-176.
33. Grap, M. J., L. Pettrey, and D. Thornby. 1997. Hemodynamic monitoring: a comparison of research and practice. Am. J. Crit. Care 6:452-456.
34. Gutierrez-Alarcon, A., M. Moguel-Torres, O. Mata-Leyva, G. Cuellar-Nevarez, T. Siqueiros-Cendon, G. Erosa, E. Ramos-Martinez, P. Talamas-Rohana, and B. Sanchez-Ramirez. 2006. Entamoeba histolytica: inflammatory process during amoebic liver abscess formation involves cyclooxygenase-2 expression in macrophages and trophozoites. Exp. Parasitol. 114:154-159.
35. Haque, R., C. D. Huston, M. Hughes, E. Houpt, and W. A. Petri, Jr. 2003. Amebiasis. N. Engl. J. Med. 348:1565-1573.
36. Harizi, H., M. Juzan, C. Grosset, M. Rashedi, and N. Gualde. 2001. Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells. Cell. Immunol. 209:19-28.
37. Helmy, K. Y., K. J. Katschke, Jr., N. N. Gorgani, N. M. Kljavin, J. M. Elliott, L. Diehl, S. J. Scales, N. Ghilardi, and M. van Lookeren Campagne. 2006. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124:915-927.
38. Huston, C. D., E. R. Houpt, B. J. Mann, C. S. Hahn, and W. A. Petri, Jr. 2000. Caspase 3-dependent killing of host cells by the parasite Entamoeba histolytica. Cell. Microbiol. 2:617-625.
39. Ivory, C. P., and K. Chadee. 2007. Activation of dendritic cells by the Gal-lectin of Entamoeba histolytica drives Th1 responses in vitro and in vivo. Eur. J. Immunol. 37:385-394.
40. Jacobs, T., I. Bruchhaus, T. Dandekar, E. Tannich, and M. Leippe. 1998. Isolation and molecular characterization of a surface-bound proteinase of Entamoeba histolytica. Mol. Microbiol. 27:269-276.
41. Kammanadiminti, S. J., B. J. Mann, L. Dutil, and K. Chadee. 2004. Regulation of Toll-like receptor-2 expression by the Gal-lectin of Entamoeba histolytica. FASEB J. 18:155-157.
42. Katz, U., S. Ankri, T. Stolarsky, Y. Nuchamowitz, and D. Mirelman. 2002. Entamoeba histolytica expressing a dominant negative N-truncated light sub-unit of its gal-lectin are less virulent. Mol. Biol. Cell 13:4256-4265.
43. Katzenstein, D., V. Rickerson, and A. Braude. 1982. New concepts of amebic liver abscess derived from hepatic imaging, serodiagnosis, and hepatic enzymes in 67 consecutive cases in San Diego. Medicine (Baltimore) 61:237-246.
44. Kempka, G., and V. Kolb-Bachofen. 1988. Binding, uptake, and transcytosis of ligands for mannose-specific receptors in rat liver: an electron microscopic study. Exp. Cell Res. 176:38-48.
45. Kim, K. A., Y. A. Lee, and M. H. Shin. 2007. Calpain-dependent calpastatin cleavage regulates caspase-3 activation during apoptosis of Jurkat T cells induced by Entamoeba histolytica. Int. J. Parasitol. 37:1209-1219.
46. Leippe, M., J. Andra, R. Nickel, E. Tannich, and H. J. Muller-Eberhard. 1994. Amoebapores. a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes. Mol. Microbiol. 14:895-904.
47. Lin, J. Y., and K. Chadee. 1992. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine. J. Immunol. 148:3999-4005.
48. Loftus, B., I. Anderson, R. Davies, U. C. Alsmark, J. Samuelson, P. Amedeo, P. Roncaglia, M. Berriman, R. P. Hirt, B. J. Mann, T. Nozaki, B, Suh, M. Pop, M. Duchene, J. Ackers, E. Tannich, M. Leippe, M. Hofer, I. Bruchhaus, U. Willhoeft, A. Bhattacharya, T. Chillingworth, C. Churcher, Z. Hance, B. Harris, D. Harris, K. Jagels, S. Moule, K. Mungall, D. Ormond, R. Squares, S. Whitehead, M. A. Quail, E. Rabbinowitsch, H. Norbertczak, C. Price, Z. Wang, N. Guillen, C. Gilchrist, S. E. Stroup, S. Bhattacharya, A. Lohia, P. G. Foster, T. Sicheritz-Ponten, C. Weber, U. Singh, C, Mukherjee, N. M, El-Sayed, W. A. Petri, Jr., C. G. Clark, T. M. Embley, B. Barrell, C. M. Fraser, and N. Hall. 2005. The genome of the protist parasite Entamoeba histolytica. Nature 433:865-868.
49. Lotter, H., T. Jacobs, I. Gaworski, and E. Tannich. 2006. Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease. Infect. Immun. 74:118-124.
50. Lushbaugh, W. B., A. F. Hofbauer, and F. E. Pittman. 1985. Entamoeba histolytica: purification of cathepsin B. Exp. Parasitol. 59:328-336.
51. Lushbaugh, W. B., A. B. Kairalia, A. F. Hofbauer, J. R. Cantey, and F. E. Pittman. 1978. Cytotoxic activity of a cell-free extract of Entamoeba histolytica. Trans. R. Soc. Trap. Med. Hyg. 72:105-106.
52. Maldonado-Bernal, C, C. J. Kirschning, Y. Rosenstein, L. M. Rocha, N. Rios-Sarabia, M. Espinosa-Cantellano, I. Becker, I. Estrada, R. M. Salazar-Gonzalez, C. Lopez-Macias, H. Wagner, J. Sanchez, and A. Isibasi. 2005. The innate immune response to Entamoeba histolytica lipopeptidophospho-glycan is mediated by Toll-like receptors 2 and 4. Parasite Immunol. 27:127-137.
53. Mann, B. J., C. Y. Chung, J. M. Dodson, L. S. Ashley, L. L Braga, and T. L. Snodgrass. 1993. Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesin map to the cysteine-rich extracellular domain of the 170-kilodalton subunit. Infect. Immun. 61:1772-1778.
54. Marinets, A., T. Zhang, N. Guillen, P. Gounon, B. Bohle, U. Vollmann, O. Scheiner, G. Wiedermann, S. L. Stanley, and M. Duchene. 1997. Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica. J. Exp. Med. 186:1557-1565.
55. Matsuno, K., H. Nomiyama, H. Yoneyama, and R. Uwatoku. 2002. Kupffer cell-mediated recruitment of dendritic cells to the liver crucial for a host defense. Dev. Immunol. 9:143-149.
56. Maurus, C. F., M. K. Schneider, D. Schmidt, G. Zund, and J. D. Seebach. 2006. Activation of human microvascular endothelial cells with TNF-alpha and hypoxia/reoxygenation enhances NK-cell adhesion, but not NK-cytotox-icity. Transplantation 81:1204-1211.
57. Moran, P., G. Rico, M. Ramiro, H. Olvera, F. Ramos, E. Gonzalez, A. Valadez, O. Curiel, E. I. Melendro, and C. Ximenez. 2002. Defective production of reactive oxygen intermediates (ROT) in a patient with recurrent amebic liver abscess. Am. J. Trop. Med. Hyg. 67:632-635.
58. Munford, R. S., P. O. Sheppard, and P. J. O'Hara. 1995. Saposin-like proteins (SAPLIP) carrv out diverse functions on a common backbone structure. J. Lipid Res. 36:1653-1663.
59. Neal, R. A., and P. Vincent. 1956. Strain variation in Entamoeba histolytica. II. The effect of serial liver passage on the virulence. Parasitology 46:173-182.
60. Olivos, A., E. Ramos, M. Nequiz, C. Barba, E. Tello, G. Castanon, A. Gonzalez, R. D. Martinez, I. Montfort, and R. Perez-Tamayo. 2005. Entamoeba histolytica: mechanism of decrease of virulence of axenic cultures maintained for prolonged periods. Exp. Parasitol. 110:309-312.
61. Pelosof, L. C, P. H. Davis, Z. Zhang, X. Zhang, and S. L Stanley, Jr. 2006. Co-ordinate but disproportionate activation of apoptotic. regenerative and inflammatory pathways characterizes the liver response to acute amebic infection. Cell. Microbiol. 8:508-522.
62. Perez-Tamayo, R., R. D. Martinez, I. Montfort, I. Becker, E. Tello, and R. Perez-Montfort. 1991. Pathogenesis of acute experimental amebic liver abscess in hamsters. J. Parasitol. 77:982-988.
63. Petri, W. A., Jr., R. Haque, and B. J. Mann. 2002. The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica. Annu. Rev. Microbiol. 56:39-64.
64. Poole, L. B., H. Z. Chae, B. M. Flores, S. L. Reed, S. G. Rhee, and B. E. Torian. 1997. Peroxidase activity of a TSA-like antioxidant protein from a pathogenic amoeba. Free Radic. Biol. Med. 23:955-959.
65. Puhl, G., K. D. Schaser, B. Vollmar, M. D. Menger, and U. Settmacher. 2003. Noninvasive in vivo analysis of the human hepatic microcirculation using orthogonal polarization spectral imaging. Transplantation 75:756-761.
66. Reed, S. L., J. G. Curd, I. Gigli, F. D. Gillin, and A. I. Braude. 1986. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica. J. Immunol. 136:2265-2270.
67. Reed, S. L., and I. Gigli. 1990. Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation bv an extracellular neutral cysteine proteinase. J. Clin, lnvestig. 86:1815-1822.
68. Reed, S. L., P. G. Sargeaunt, and A, L Braude. 1983. Resistance to lysis by human serum of pathogenic Entamoeba histolytica. Trans. R. Soc. Trop. Med. Hyg. 77:248-253.
69. Rigothier, M. C., H. Khun, P. Tavares, A. Cardona, M. Huerre, and N. Guillen. 2002. Fate of Entamoeba histolytica during establishment of amoebic liver abscess analyzed by quantitative radioimaging and histology. Infect. Immun. 70:3208-3215.
70. Sanchez-Ramirez, B., M. Ramirez-Gil, I. Vazquez-Moetezuma, E. Ramos-Martinez, and P. Talamas-Rohana. 2004. Entamoeba histolytica: induction of cyclooxygenase-2 expression during amoebic liver abscess formation in hamsters (Mesocricetus auratus). Exp. Parasitol. 106:119-125.
71. Santi-Rocca, J., C. Weber, G. Guigon, O. Sismeiro, J. Y. Coppee, and N. Guillen. 2008. The lysine- and glutamic acid-rich protein KERP1 plays a role in Entamoeba histolytica liver abscess pathogenesis. Cell. Microbiol. 10:202-217.
72. Sato, D., K. Nakada-Tsukui, M. Okada, and T. Nozaki. 2006. Two cysteine protease inhibitors, EhICPl and 2, localized in distinct compartments, negatively regulate secretion in Entamoeba histolytica. FEBS Lett. 580:5306-5312.
73. Schultz, H., E. Csernok, K. Herlyn, P. H. Reichel, F. Moosig, O. A. Cornely, M. K. Fagerhol, and W. L. Gross. 2003. ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations. Clin. Exp. Rheumatol. 21:S117-S120.
74. Seguin, R., B. J. Mann, K. Keller, and K. Chadee. 1995. Identification of the galactose-adherence lectin epitopes of Entamoeba histolytica that stimulate tumor necrosis factor-alpha production by macrophages. Proc. Natl. Acad. Sci. USA 92:12175-12179.
75. Seguin, R., B. J. Mann, K. Keller, and K. Chadee. 1997. The tumor necrosis factor alpha-stimulating region of galactose-inhibitable lectin of Entamoeba histolytica activates gamma interferon-primed macrophages for amebicidal activity mediated by nitric oxide. Infect. Immun. 65:2522-2527.
76. Seigneur, M., J. Mounier, M. C. Prevost, and N. Guillen. 2005. A lysine- and glutamic acid-rich protein. KERP1, from Entamoeba histolytica binds to human enterocytes. Cell. Microbiol. 7:569-579.
77. Seydel, K. B., S. J. Smith, and S. L. Stanley, Jr. 2000. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model of disease. Infect. Immun. 68:400-402.
78. Seydel, K. B., and S. L. Stanley, Jr. 1998. Entamoeba histolytica induces host cell death in amebic liver abscess by a non-Fas-dependent, non-tumor necrosis factor alpha-dependent pathway of apoptosis. Infect. Immun. 66:2980-2983.
79. Singer, I. I., D. W. Kawka, S. Sehloemann, T. Tessner, T. Riehl, and W. F. Stenson. 1998. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115:297-306.
80. Talamas-Rohana, P., and I. Meza. 1988. Interaction between pathogenic amebas and fibronectin: substrate degradation and changes in cytoskeleton organization. J. Cell Biol. 106:1787-1794.
81. Thompson, P. E., D. McCarthy, and J. W. Reinertson. 1954. Observations on the virulence of Entamoeba histolytica during prolonged sub cultivation. Am. J. Hyg. 59:249-261.
82. Tsutsumi, V., R. Mena-Lopez, F. Anaya-Velazquez, and A. Martinez-Palomo. 1984. Cellular bases of experimental amebic liver abscess formation. Am. J. Pathol. 117:81-91.
83. Velazquez, J. R., P. Llaguno, J. Fernandez-Diez, M. Perez-Rodriguez, J. Arellano, M. Lopez-Osuna, and R. R. Kretschmer. 1995. Antigen induced eosinophilia protects gerbils (Meriones unguiculatus) against experimental amebic abscess of the liver. Arch. Med. Res. 26:S93-S98.
84. Vines, R. R., G. Ramakrishnan, J. B. Rogers, L. A. Lockhart, B. J. Mann, and W. A. Petri, Jr. 1998. Regulation of adherence and virulence by the Entamoeba histolytica lectin cytoplasmic domain, which contains a beta2 integrin motif. Mol. Biol. Cell 9:2069-2079.
85. Walzer, T., M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier. 2005. Natural-killer cells and dendritic cells: "lunion fait la force." Blood 106: 2252-2258.
86. Watanabe, T., H. Katsukura, T. Chiba, T. Kita, and Y. Wakatsuki. 2007. Periportal and sinusoidal liver dendritic cells suppressing T helper type 1-mediated hepatitis. Gut 56:1445-1451.
87. Weber, C., S. Blazquez, S. Marion, C. Ausseur, D. Vats, M. Krzeminski, M. C. Rigothier, R. C. Maroun, A. Bhattacharya, and N. Guillen. 2008. Bioinformatics and functional analysis of an Entamoeba histolytica manno-syltransferase necessary for parasite complement resistance and hepatical infection. PLoS Negl. Trop. Dis. 2:e165.
88. WHO. 1997. WHO/PAHO/UNESCO report of a consultation of experts on amoebiasis. Wkly. Epidemiol. Rec. 72:97-100.
89. Zhang, X., Z. Zhang, D. Alexander, R. Bracha, D. Mirelman, and S. L. Stanley, Jr. 2004. Expression of amoebapores is required for full expression of Entamoeba histolytica virulence in amebic liver abscess but is not necessary for the induction of inflammation or tissue damage in amebic colitis. Infect. Immun. 72:678-683.
90. Zhang, Z., S. Mahajan, X. Zhang, and S. L. Stanley, Jr. 2003. Tumor necrosis factor alpha is a key mediator of gut inflammation seen in amebic colitis in human intestine in the SC1D mouse-human intestinal xenograft model of disease. Infect. Immun. 71:5355-5359.